Nizatidine
NDC Package 68258-3006-1

11-digit billing NDC: 68258300601

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Nizatidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. Marketed by Dispensing Solutions Inc., this product is identified by NDC 68258-3006 and is authorized under FDA application ANDA075616.

Identification & Billing

NDC Package Code
68258-3006-1
Package Description
30 CAPSULE in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
68258300601
RxNorm Crosswalk
RxCUI: 198041 - nizatidine 300 MG Oral Capsule

Clinical Specifications

Proprietary Name
Nizatidine
Dosage Form
-
Usage Information
Nizatidine is indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks.Nizatidine is indicated for maintenance therapy for duodenal ulcer patients, at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. The consequences of continuous therapy with nizatidine for longer than 1 year are not known.Nizatidine is indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to GERD.Nizatidine is indicated for up to 8 weeks for the treatment of active benign gastric ulcer. Before initiating therapy, care should be taken to exclude the possibility of malignant gastric ulceration.

Regulatory & Marketing

Labeler Name
Dispensing Solutions Inc.
FDA Application #
ANDA075616
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-22-2009
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68258-3006-1 identifies a specific commercial package of 30 capsule in 1 bottle, plastic of Nizatidine, labeled by Dispensing Solutions Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Dispensing Solutions Inc. on January 22, 2009. The current certification is valid through December 31, 2017.

How is this Dispensing Solutions Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68258300601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68258-3006-1
11-Digit CMS (5-4-2)
68258-3006-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.